Trial Profile
A retrospective study of abiraterone acetate in men with metastatic castration-resistant prostate cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 16 May 2016 New trial record